Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179310 | SCV000231540 | benign | not specified | 2015-01-16 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000179310 | SCV000269165 | benign | not specified | 2014-10-31 | criteria provided, single submitter | clinical testing | Arg131His in exon 7 of HSD17B4: This variant is not expected to have clinical si gnificance because it has been identified in 46% (3954/8596) of European America n chromosomes and 18% (776/4404) of African American chromosomes by the NHLBI Ex ome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs25640). |
Prevention |
RCV000179310 | SCV000304079 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000362861 | SCV000452107 | benign | Perrault syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000391832 | SCV000452108 | benign | Bifunctional peroxisomal enzyme deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000179310 | SCV000728564 | benign | not specified | 2017-05-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000676075 | SCV001158876 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001517001 | SCV001725385 | benign | Bifunctional peroxisomal enzyme deficiency; Perrault syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000391832 | SCV001762860 | benign | Bifunctional peroxisomal enzyme deficiency | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000362861 | SCV001762861 | benign | Perrault syndrome 1 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676075 | SCV000801810 | benign | not provided | 2015-10-26 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000391832 | SCV001457634 | benign | Bifunctional peroxisomal enzyme deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000179310 | SCV001741765 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000179310 | SCV001953418 | benign | not specified | no assertion criteria provided | clinical testing |